{
  "note_id": "gold_t2dm_007",
  "scenario": "t2dm",
  "persona": "gold",
  "note_text": "**Clinical Note**\n\n**Patient Name:** Lisa Anderson  \n**Date of Visit:** [Today's Date]  \n**Age:** 45  \n**Gender:** Female  \n**Occupation:** Accountant  \n**BMI:** 32.4  \n\n**Chief Complaint:**  \nDiabetes follow-up.\n\n**History of Present Illness:**  \nLisa Anderson is a 45-year-old female with a 3-year history of Type 2 Diabetes Mellitus who presents for routine management. Her last HbA1c, 3 months ago, was 8.2%, and recent lab results show an improvement to 7.8%. She reports home glucose readings ranging from 160-220 mg/dL fasting and 180-250 mg/dL postprandial. She is currently taking Metformin 1000mg twice daily with meals and reports occasional gastrointestinal upset, though she is generally tolerating the medication. She denies any episodes of hypoglycemia. She underwent a dilated eye exam 8 months ago, which revealed mild retinopathy. Her foot exam today is unremarkable. Comorbid conditions include controlled hypertension on Lisinopril and hyperlipidemia on Atorvastatin. Lifestyle factors include a sedentary job, minimal exercise, struggles with portion control, and daily soda consumption. She denies symptoms of polyuria, polydipsia, weight loss, and visual changes but does report occasional tingling in her feet. She had gestational diabetes during pregnancy but is not currently planning pregnancy. Her menstrual cycles are irregular, likely due to obesity and insulin resistance.\n\n**Review of Systems:**  \n- **General:** No weight loss.  \n- **Eyes:** No visual changes.  \n- **Neurological:** Tingling in feet occasionally, no other neurological symptoms.  \n- **Endocrine:** No polyuria or polydipsia.  \n- **Skin:** No wounds or calluses.\n\n**Past Medical History:**  \n- Type 2 Diabetes Mellitus, diagnosed 3 years ago  \n- Hypertension  \n- Hyperlipidemia  \n\n**Medications:**  \n- Metformin 1000mg twice daily  \n- Lisinopril 20mg daily  \n- Atorvastatin 20mg daily  \n\n**Allergies:**  \nNo known drug allergies.\n\n**Social History:**  \n- Occupation: Accountant, sedentary job  \n- Exercise: Minimal  \n- Diet: Struggles with portion control, consumes soda daily  \n- Smoking: Non-smoker  \n- Alcohol: Social drinker\n\n**Physical Examination:**  \n- **Vital Signs:** BP 128/78 mmHg, HR 78 bpm, Weight 185 lbs, BMI 32.4, Temperature 98.6\u00b0F  \n- **General:** Alert, obese, pleasant  \n- **Cardiovascular:** Regular rate and rhythm, no murmurs, peripheral pulses 2+ dorsalis pedis and posterior tibial bilaterally  \n- **Respiratory:** Clear to auscultation bilaterally  \n- **Extremities:** Monofilament test shows protective sensation intact bilaterally, skin intact without wounds or calluses, no edema, pedal pulses palpable  \n- **Feet:** No deformities, nails trimmed, no fungal infection  \n\n**Assessment and Plan:**  \n1. **Type 2 Diabetes Mellitus, improving control (ICD-10: E11.65):**  \n   - Add Semaglutide 0.25mg subcutaneously weekly, increase to 0.5mg after 4 weeks for glucose control and weight loss.  \n   - Continue Metformin 1000mg twice daily.  \n   - Order HbA1c in 3 months.  \n   - Referral to diabetes educator for nutrition counseling.  \n   - Lifestyle modifications: Eliminate sugar-sweetened beverages, portion control, increase physical activity to 150 min/week.  \n   - Weight loss goal: 5-10% body weight over 6 months.  \n   - Patient education on glucose targets and HbA1c goals.  \n\n2. **Obesity (ICD-10: E66.9):**  \n   - Addressed lifestyle changes and weight loss strategies.  \n\n3. **Essential hypertension, controlled (ICD-10: I10):**  \n   - Continue Lisinopril 20mg daily.  \n\n4. **Hyperlipidemia (ICD-10: E78.5):**  \n   - Continue Atorvastatin 20mg daily.  \n\n5. **Mild Retinopathy:**  \n   - Referral to ophthalmology for annual dilated eye exam.  \n\n6. **Vaccinations:**  \n   - Ensure flu vaccine, check pneumococcal status.  \n\n7. **Pregnancy planning:**  \n   - Discussed preconception counseling and contraception needs.  \n\n**Time Spent:**  \n25 minutes with extensive medication counseling and lifestyle education.\n\n**Billing Level:**  \n99214 (Established patient, moderate to high complexity due to uncontrolled chronic disease).\n\n**Medical Decision Making:**  \nGlycemic control is improving with HbA1c reduced to 7.8%. Decision to add GLP-1 agonist for further glucose control and weight management, considering cardiovascular benefits. Discussed injection technique and potential side effects. Addressed lifestyle modification challenges. Screening for complications is current, except for ophthalmology, for which a referral was placed.",
  "demographics": {
    "age": 45,
    "gender": "F",
    "occupation": "accountant",
    "name": "Lisa Anderson"
  },
  "generated_at": "2026-02-14T01:56:20.376836",
  "ground_truth_scores": {
    "completeness": 85,
    "accuracy": 90,
    "compliance": 80,
    "risk": 88,
    "clarity": 92
  }
}